Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00178594 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 100 to 1000v18 Show 4 more changesShow less
    • Primary and study completion dates: Jan 2024 to Jan 2028
    • Study sites: 1 to 2
    • Eligibility criteria expanded, about 6 words
    • Study description expanded, about 14 words
  2. Primary and study completion dates: Jan 2022 to Jan 2024
    • Site contact updated
    v17
  3. Primary and study completion dates: Jan 2020 to Jan 2022v16
  4. Primary and study completion dates: Jan 2016 to Jan 2020v15
  5. Primary completion date: Jan 2015 to Jan 2016v14
Show 12 earlier versionsHide 12 earlier versions
  1. Primary completion date: Jan 2014 to Jan 2015
    • Study completion date: Jan 2014 to Jan 2016
    v13
  2. Primary completion date: Jan 2014
    • Study completion date: Jan 2011 to Jan 2014
    v12
  3. Study completion date: Jul 2009 to Jan 2011v11
  4. 3 versions Re-verified since Jul 10, 2009, no change to tracked fieldsv8-v10
  5. Study completion date: Dec 2008 to Jul 2009v7
  6. Re-verified, no change to tracked fieldsv6
  7. Study completion date: Dec 2008v5
  8. 3 versions Re-verified since Mar 27, 2006, no change to tracked fieldsv2-v4
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.
Trial Details
NCT Number NCT00178594
Lead Sponsor The University of Texas Health Science Center, Houston
Conditions
(from sponsor)		 Blood Coagulation Disorders, Inherited, Thrombotic Disorder
Related terms Blood Coagulation Disorders, Inherited, Thrombosis
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov